TBD at CPHI Barcelona 2023
🌟 TBD Pharmatech is excited to attend this year’s CPHI Barcelona 2023 on 24-26 Oct 2023. CPHI Barcelona brings together the key experts, innovators, and suppliers to showcase their state-of-the-art…
Read moreResources
-
SEPTEMBER 26, 2023
-
-
SEPTEMBER 1, 2023
Project: PharmaBoost – EstLat Alliance in Drug Development
Drug substance development for smoking cessation On September 1st, 2023, TBD Pharmatech started together with the Latvian Institute of Organic Synthesis a new project PharmaBoost – EstLat Alliance…
Read more-
-
AUGUST 15, 2023
Co-authored scientific publication in “Pharmaceuticals” – TMTHSI in metal-free click chemistry
A study co-authored by TBD and published in “Pharmaceuticals” in August 2023 has detailed the properties and potential applications in metal-free click chemistry for a new compound, tetramethylthiocycloheptyne…
Read more-
-
JUULI 1, 2023
TBD Pharmatech volleyball team
TBD believes that community engagement and sportsmanship go hand in hand in fostering a vibrant, healthy work environment. The company takes immense pride in supporting its women’s volleyball…
Read more-
-
MAI 25, 2023
TBD Pharmatech’s Disc Golf Adventure: A Tale of Teamwork
First Foray into Disc Golf In September last year, TBD Pharmatech plunged into the unfamiliar world of disc golf. Our debut team – Sander Kotkas, Jürgen Vahter, and Merle Muruvee – represented…
Read more-
-
MAI 25, 2023
Project: Drug substance development for pain reduction
The project aims to develop a new, more effective technology for synthesizing an active pharmaceutical ingredient (API) for a drug used primarily as a pain reliever for moderate to severe pain. The…
Read more-
Ravimainete arendaja ja tootja, mis pakub peenkeemia lahendusi farmaatsia- ja biotehnoloogia ettevõttetele.